KONSTANTINOS MAKRIS to Drug Resistance, Bacterial
This is a "connection" page, showing publications KONSTANTINOS MAKRIS has written about Drug Resistance, Bacterial.
Connection Strength
0.034
-
Optimal duration of concomitant nonbismuth quadruple therapy as first-line therapy for Helicobacter pylori: a prospective, open-label, comparative study. Eur J Gastroenterol Hepatol. 2019 Oct; 31(10):1206-1210.
Score: 0.034